RMgmDB - Rodent Malaria genetically modified Parasites

Summary

RMgm-1138
Malaria parasiteP. berghei
Genotype
TaggedGene model (rodent): PBANKA_0506500; Gene model (P.falciparum): PF3D7_1022300; Gene product: ZIP domain-containing protein, putative (ZIP domain-containing protein, ZIPCO)
Name tag: HA
Phenotype Liver stage;
Last modified: 26 October 2014, 13:47
  *RMgm-1138
Successful modificationThe parasite was generated by the genetic modification
The mutant contains the following genetic modification(s) Gene tagging
Reference (PubMed-PMID number) Reference 1 (PMID number) : 25257508
MR4 number
Parent parasite used to introduce the genetic modification
Rodent Malaria ParasiteP. berghei
Parent strain/lineP. berghei ANKA
Name parent line/clone P. berghei ANKA 507cl1 (RMgm-7)
Other information parent lineP.berghei ANKA 507cl1 (RMgm-7) is a reference ANKA mutant line which expresses GFP under control of a constitutive promoter. This reference line does not contain a drug-selectable marker (PubMed: PMID: 16242190).
The mutant parasite was generated by
Name PI/ResearcherSahu T; Menard R; Baldacci P
Name Group/DepartmentUnité de Biologie et Génétique du Paludisme
Name InstituteInstitut Pasteur
CityParis
CountryFrance
Name of the mutant parasite
RMgm numberRMgm-1138
Principal nameZIPCO-HA
Alternative name
Standardized name
Is the mutant parasite cloned after genetic modificationYes
Phenotype
Asexual blood stageNot different from wild type
Gametocyte/GameteNot tested
Fertilization and ookineteNot tested
OocystNot tested
SporozoiteNot different from wild type
Liver stageTo assess the expression of ZIPCO-HA in sporozoites, Western blot analysis was performed using anti-HA monoclonal antibodies. No specific band was detected at the expected 35 kDa in ZIPCO-HA sporozoites. To investigate ZIPCO-HA production by and localization in liver stages, ZIPCO-HA infected HepG2 cells were stained using a monoclonal anti-HA antibody. A specific signal was detected in EEFs at 48 and 63 hpi. At 48 hpi, there was a punctuated labeling within and at the periphery of the developing parasite. Double labeling with MSP-1, a parasite protein located at the plasma membrane, showed regions of overlap with the HA signal. In more advanced EEFs at the cytomere stage, the HA labeling was detected around groups of nuclei and again there was overlap with the MSP1 signal. These data strongly suggest that ZIPCOHA is mainly located at the parasite plasma membrane.
Additional remarks phenotype

Mutant/mutation
The mutant  expresses a C-terminal HA-tegged version of  ZIPCO (zinc transporter, putative; ZIP domain-containing protein) and expresses GFP under the control of the constitutive eef1a promoter.


Protein (function)
PBANKA_050650 is predicted to code for a protein with seven trans-membrane (TM) domains, including a putative N-terminal signal peptide, and has been annotated as a putative zinc transporter due to the presence of a conserved ZIP domain (Pfam02535). The ZIP family of proteins have a conserved signature of 15 amino acids, located either completely or partially within the fourth TM region, and 13 of them are present in PBANKA_050650. Sequence comparison using the forty sequences that constitute the seed of the Pfam02535 profile found that the well-conserved amino acids of this profile are present in PBANKA_050650. The genomes of P. falciparum, P. chabaudi, P. knowlesi, P. vivax, Saccharomyces cerevisiae and Arabidopsis thaliana were screened with the Pfam02535 profile, and a phylogenetic tree was generated that indicated the presence of two paralogs of the ZIP family in the screened Plasmodium species. In P. berghei, the paralog of PBANKA_050650 is PBANKA_010770, annotated as a putative permease. PBANKA_050650 thus encodes a protein of the ZIP family, which was named ZIP domain-containing protein, ZIPCO.

Phenotype
Phenotype analyses of a mutant lacking ZIPCO (RMgm-1137) indicate that parasites undergo a delayed and inefficient schizogonic process in the hepatocyte, resulting in reduced formation of merozoites. Evidence is presented that iron or zinc supplementation to the medium rescues the growth defect of liver stages suggesting that ZIPCO is required for parasite utilization of iron and possibly zinc, consistent with its predicted function as a metal transporter.

Phenotype analysys of the mutant expressing HA-tagged ZIPCO showed peak expression of ZIPCO in late liver stages and evidence is presented for localisation of ZIPCO in the parasite plasma membrane.

Additional information
Quantitative RT-PCR analysis of various P. berghei developmental stages indicated that PBANKA_050650 transcripts were sevenfold higher in sporozoites than mixed RBC or exo-erythrocytic forms (EEFs) developing inside HepG2 hepatoma cells.

Other mutants
RMgm-1137: A  mutant lacking expression of ZIPCO.


  Tagged: Mutant parasite with a tagged gene
Details of the target gene
Gene Model of Rodent Parasite PBANKA_0506500
Gene Model P. falciparum ortholog PF3D7_1022300
Gene productZIP domain-containing protein, putative
Gene product: Alternative nameZIP domain-containing protein, ZIPCO
Details of the genetic modification
Name of the tagHA
Details of taggingC-terminal
Additional remarks: tagging
Commercial source of tag-antibodies
Type of plasmid/construct(Linear) plasmid double cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Selectable marker used to select the mutant parasitehdhfr
Promoter of the selectable markerpbdhfr
Selection (positive) procedurepyrimethamine
Selection (negative) procedureNo
Additional remarks genetic modificationThe plasmid pBC-zipco-HA-hDHFR contains a HA-FLAG tag fused in frame to the carboxy terminus of the ZIPCO coding sequence, followed by the 3’UTR of Pbhsp70 and the hDHFR cassette.

The entire zipco gene (1.4 kb) was cloned between ApaI and ClaI sites, upstream of the
HA-FLAG sequence in the pBC-HA-hDHFR plasmid described in Boisson et al (2011). The 3' UTR of zipco (1 kb) was introduced between NotI and AscI sites. The resulting plasmid pBC-zipco-HA was sequenced, and the HA sequence was found to be in phase with the carboxy terminus of ZIPCO. The plasmid was digested with ApaI and AscI and transfected into ANKA-GFP (WT-F) parasites
Additional remarks selection procedure
Primer information: Primers used for amplification of the target sequences  Click to view information
Primer information: Primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4
Sequence Primer 5
Additional information primer 5
Sequence Primer 6
Additional information primer 6